HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes

The HIV epidemic among injecting drug users (IDUs) has led to greater support for the development of the harm-reduction perspective. This has proven to be a driving force for initially reluctant policy makers, managers and health care providers and has facilitated the implementation of harm-reductio...

Descripción completa

Detalles Bibliográficos
Autores: Trujols, J, Iraurgi, I, Sola, I, Ballesteros, J, Sinol, N, Batlle, F, de Los Cobos, JP
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2010
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p15201
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15201
Access Level:acceso abierto
Palabra clave:injecting drug users
harm- and risk-reduction programmes
HIV prevention and management
injection-related HIV risk practices
sex-related HIV risk practices
id ES_2e1cbe12a5d62ecf5ed32bb6a0b96ae7
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p15201
network_acronym_str ES
network_name_str España
repository_id_str
spelling HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmesTrujols, JIraurgi, ISola, IBallesteros, JSinol, NBatlle, Fde Los Cobos, JPinjecting drug usersharm- and risk-reduction programmesHIV prevention and managementinjection-related HIV risk practicessex-related HIV risk practicesThe HIV epidemic among injecting drug users (IDUs) has led to greater support for the development of the harm-reduction perspective. This has proven to be a driving force for initially reluctant policy makers, managers and health care providers and has facilitated the implementation of harm-reduction programmes. This article presents recent data, both global and at the European and Spanish levels, about a) the epidemiological situation of HIV infection among IDUs, and b) the state of development of harm-reduction programmes. The incidence of HIV infection among IDUs not only continues to grow in different areas of, for example, Southeast Asia or Eastern Europe, but has even shown an upturn in cities or specific IDU groups in parts of Western Europe with apparently comprehensive harm-reduction strategies. On the other hand, of the 158 countries that acknowledge illegal drug use via injection in their territory, only 82 support harm reduction, explicitly in national policy documents and/or through the implementation or tolerance of interventions such as needle exchange programmes or opioid agonist programmes. These data, in conjunction with the high-quality and consistent evidence on the efficacy and effectiveness of harm- and risk-reduction programmes for HIV prevention and management among IDUs, should serve as a call to avoid complacency with regard to the diversification, accessibility and coverage of harm- and risk-reduction programmes for IDUs.SOCIDROGALCOHOL2010info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15201AdiccionesISSN: 02144840reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Españolinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p152012026-06-14T12:41:47Z
dc.title.none.fl_str_mv HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes
title HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes
spellingShingle HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes
Trujols, J
injecting drug users
harm- and risk-reduction programmes
HIV prevention and management
injection-related HIV risk practices
sex-related HIV risk practices
title_short HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes
title_full HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes
title_fullStr HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes
title_full_unstemmed HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes
title_sort HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes
dc.creator.none.fl_str_mv Trujols, J
Iraurgi, I
Sola, I
Ballesteros, J
Sinol, N
Batlle, F
de Los Cobos, JP
author Trujols, J
author_facet Trujols, J
Iraurgi, I
Sola, I
Ballesteros, J
Sinol, N
Batlle, F
de Los Cobos, JP
author_role author
author2 Iraurgi, I
Sola, I
Ballesteros, J
Sinol, N
Batlle, F
de Los Cobos, JP
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv injecting drug users
harm- and risk-reduction programmes
HIV prevention and management
injection-related HIV risk practices
sex-related HIV risk practices
topic injecting drug users
harm- and risk-reduction programmes
HIV prevention and management
injection-related HIV risk practices
sex-related HIV risk practices
description The HIV epidemic among injecting drug users (IDUs) has led to greater support for the development of the harm-reduction perspective. This has proven to be a driving force for initially reluctant policy makers, managers and health care providers and has facilitated the implementation of harm-reduction programmes. This article presents recent data, both global and at the European and Spanish levels, about a) the epidemiological situation of HIV infection among IDUs, and b) the state of development of harm-reduction programmes. The incidence of HIV infection among IDUs not only continues to grow in different areas of, for example, Southeast Asia or Eastern Europe, but has even shown an upturn in cities or specific IDU groups in parts of Western Europe with apparently comprehensive harm-reduction strategies. On the other hand, of the 158 countries that acknowledge illegal drug use via injection in their territory, only 82 support harm reduction, explicitly in national policy documents and/or through the implementation or tolerance of interventions such as needle exchange programmes or opioid agonist programmes. These data, in conjunction with the high-quality and consistent evidence on the efficacy and effectiveness of harm- and risk-reduction programmes for HIV prevention and management among IDUs, should serve as a call to avoid complacency with regard to the diversification, accessibility and coverage of harm- and risk-reduction programmes for IDUs.
publishDate 2010
dc.date.none.fl_str_mv 2010
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15201
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15201
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv SOCIDROGALCOHOL
publisher.none.fl_str_mv SOCIDROGALCOHOL
dc.source.none.fl_str_mv Adicciones
ISSN: 02144840
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405381711626240
score 15.812429

Similares en LA Referencia